searchMupirocinSystematic (IUPAC) name9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[ [(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acidIdentifiersCAS number 12650-69-0ATC code D06AX09 R01AX06PubChem 446596Chemical dataFormula C26H44O9Mol. mass 500.622 g/molPharmacokinetic.

skin infections, for example, furuncle, impetigo, open wounds etc. It is suggested, however, bactroban topical vs bactroban nasal ointment mupirocin not be used for extended periods of time, or indiscriminately, as resistance does develop, and could, if it becomes bactroban topical vs bactroban nasal ointment destroy bactroban topical vs bactroban nasal ointment value as a topical treatment for bacterial bactroban topical vs bactroban nasal ointment infections, bactroban topical vs bactroban nasal ointment example, furuncle, impetigo, open wounds etc. It is used as a treatment for MRSA. It may also result in overgrowth bactroban topical vs bactroban nasal ointment non-susceptible organisms.[edit] SourcesThe original manufacturer's (GlaxoSmithKline) product is Bactroban. It is also useful in the treatment of methicillin-resistant Staphyolococcus aureus (MRSA), which is simply called Mupirocin Ointment.[2] MupirocinFrom Wikipedia, the free encyclopedia(Redirected from Bactroban)Jump to: navigation, searchMupirocinSystematic (IUPAC) name9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[ [(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acidIdentifiersCAS number 12650-69-0ATC code D06AX09.

(IUPAC) name9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[.